Did the universal zero-markup drug policy lower healthcare expenditures? Evidence from Changde, China
Abstract Background The zero-markup drug policy (also known as the universal zero-markup drug policy (UZMDP)) was implemented in stages beginning with primary healthcare facilities in 2009 and eventually encompassing city public hospitals in 2016. This policy has been a central pillar of Chinese hea...
Saved in:
Main Authors: | Zixuan Peng (Author), Chaohong Zhan (Author), Xiaomeng Ma (Author), Honghui Yao (Author), Xu Chen (Author), Xinping Sha (Author), Peter C. Coyte (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current situation and distribution equality of public health resource in China
by: Honghui Yao, et al.
Published: (2020) -
The impact of China's zero markup drug policy on drug costs for managing Parkinson's disease and its complications: an interrupted time series analysis
by: Ruilin Wang, et al.
Published: (2023) -
Differential effect of China's Zero Markup Drug Policy on provider-induced demand in secondary and tertiary hospitals
by: Xiaoxi Zhang, et al.
Published: (2024) -
Medical service pricing and pharmaceutical supply chain coordination contracts under the zero-markup drug policy
by: Nan Zhou, et al.
Published: (2023) -
Different impacts of the zero-markup drug policy on county general and traditional Chinese medicine hospitals: evidence from Shandong province, China
by: Xiaofeng Jiang, et al.
Published: (2020)